The other day, while preparing one of my favorite meals, I reached for the pan where I’d just fried pork chops. Instead of rinsing it, I poured water straight into the sizzling skillet, watching the ...

Fluticasone (brand name Flovent) is a prescription corticosteroid used to prevent breathing difficulties, chest tightness, wheezing and coughing caused by respiratory disorders such as COPD. It works ...

Common symptoms of chronic obstructive pulmonary disease, or COPD, include shortness of breath, a frequent cough or cough that produces a lot of mucus, wheezing, and tightness in the chest. Excess ...

Trelegy Ellipta is a once-daily, single inhaler triple therapy from GSK, in collaboration with Innoviva, approved as a long-term maintenance treatment for certain patients with chronic obstructive ...

Ipratropium (brand name, Atrovent HFA; Boehringer-Ingelheim) is a short-acting bronchodilator. It is used to prevent wheezing, shortness of breath, coughing, and chest tightness in people with COPD.

COPD is among the leading causes of death in industrialized countries, and new pharmacological treatments are being developed to help patients with this disease. But a spectrum of non-pharmacological ...

There is no need to do any special preparation for this test. However, if you are on oxygen therapy, oxygen values must be constant for 20 minutes before the test. If you are taking medication to make ...

Although there is no cure for COPD yet, there are several approved treatments that can help manage the disease and ease symptoms. Learn more about some of the specific therapies used to treat this ...

Caroline Gainer is from West Virginia, the state with the highest rate of COPD in the United States. She was diagnosed with moderate-to-severe COPD in 2013 after a pneumothorax (lung collapse). After ...

People with chronic obstructive pulmonary disease (COPD) who also have gastroesophageal reflux disease (GERD) — commonly called acid reflux — have a higher risk of experiencing acute exacerbations, a ...

Note: This is the first part of a three-part series written in collaboration with respiratory therapist Mark W. Mangus Sr., RRT, RPFT, FAARC, and oxygen expert Ryan Diesem. One of the more hotly ...